Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.61 |
| ▸ | ATM | Q13315 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | ACHE | P22303 | 2/20 | 0.57 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA7 | P43166 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.50 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | CD44 | P16070 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.44 |
| ▸ | HTR1B | P28222 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL40704 | 1.00 | — | — | |
| SCHEMBL10941713 | 0.96 | TRPA1 (0.58) | TRPA1ATMTSHRACHECYP2A6 | |
| Water SCHEMBL11662813 | 0.96 | TRPA1 (0.58) | TRPA1ATMTSHRACHECYP2A6 | |
| SCHEMBL31498525 | 0.96 | TRPA1 (0.58) | TRPA1ATMTSHRACHECYP2A6 | |
| Ammonia Solution, Strong SCHEMBL9810941 | 0.96 | TRPA1 (0.58) | TRPA1ATMTSHRACHECYP2A6 | |
| Ammonia Solution, Strong SCHEMBL2017512 | 0.96 | TRPA1 (0.58) | TRPA1ATMTSHRACHECYP2A6 | |
| Hydrochloric Acid SCHEMBL22194330 | 0.96 | TRPA1 (0.58) | TRPA1ATMTSHRACHECYP2A6 | |
| Benzene SCHEMBL22829865 | 0.96 | TRPA1 (0.58) | TRPA1ATMTSHRACHECYP2A6 | |
| Bromide SCHEMBL21173634 | 0.96 | TRPA1 (0.58) | TRPA1ATMTSHRACHECYP2A6 | |
| SCHEMBL7695351 | 0.96 | TRPA1 (0.58) | TRPA1ATMTSHRACHECYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105084497-A | Treatment agent for removing trimethylbenzene in waste water in alkyd resin workshop | WENZHOU HONGCHENGXIANG TECHNOLOGY CO LTD | 2015-11-25 | — | — | CN | disclosed |
| CN-105060574-A | Method of removing trimethylbenzene from workshop waste water of alkyd resin | WENZHOU HONGCHENGXIANG TECHNOLOGY CO LTD | 2015-11-18 | — | — | CN | disclosed |
| US-20120202766-A1 | N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS | PHARMASSET, INC. (US) | 2012-08-09 | — | — | US | disclosed |
| CN-102304011-A | Method for producing 1,2,4-trimethylbenzene by C9 aromatic hydrocarbon isomerization | ZHENJIANG ZHENGDAN CHEMICAL INDUSTRY CO LTD | 2012-01-04 | — | — | CN | disclosed |
| US-20070078080-A1 | N4-Acylcytosine Nucleosides for Treatment of Viral Infections | GILEAD PHARMASSET LLC | 2007-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070078080-A1 | N4-Acylcytosine Nucleosides for Treatment of Viral Infections | ENTPD5, DUT, NT5C3B | TRPA1 4883/4885ATM 4780/4885TSHR 4176/4885 |
| US-20120202766-A1 | N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS | ENTPD5, DUT, NT5C3B | TRPA1 4883/4885ATM 4787/4885TSHR 4165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.